These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30745066)

  • 1. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Schizophr Res; 2019 Jun; 208():41-43. PubMed ID: 30745066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort.
    Chung Y; Allswede D; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Neuroimage Clin; 2019; 23():101862. PubMed ID: 31150956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
    Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Biomarkers of Vulnerability and Progression to Psychosis.
    Cannon TD
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S127-32. PubMed ID: 26656880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain morphologic changes in early stages of psychosis: Implications for clinical application and early intervention.
    Takahashi T; Suzuki M
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):556-571. PubMed ID: 29717522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and Specific Cortical Volume Asymmetries in Individuals With Psychosis Risk Syndrome and Schizophrenia: A Mixed Cross-sectional and Longitudinal Perspective.
    Damme KSF; Vargas T; Calhoun V; Turner J; Mittal VA
    Schizophr Bull; 2020 Apr; 46(3):713-721. PubMed ID: 31682728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Worthington MA; Walker EF; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD
    Schizophr Res; 2021 Jan; 227():95-100. PubMed ID: 33046334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders.
    Koutsouleris N; Davatzikos C; Borgwardt S; Gaser C; Bottlender R; Frodl T; Falkai P; Riecher-Rössler A; Möller HJ; Reiser M; Pantelis C; Meisenzahl E
    Schizophr Bull; 2014 Sep; 40(5):1140-53. PubMed ID: 24126515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
    Chung Y; Haut KM; He G; van Erp TGM; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Cannon TD;
    Schizophr Res; 2017 Nov; 189():169-174. PubMed ID: 28245961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone WS; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Schizophr Bull; 2022 Mar; 48(2):395-404. PubMed ID: 34581405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.
    Koutsouleris N; Borgwardt S; Meisenzahl EM; Bottlender R; Möller HJ; Riecher-Rössler A
    Schizophr Bull; 2012 Nov; 38(6):1234-46. PubMed ID: 22080496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program.
    Collin G; Seidman LJ; Keshavan MS; Stone WS; Qi Z; Zhang T; Tang Y; Li H; Anteraper SA; Niznikiewicz MA; McCarley RW; Shenton ME; Wang J; Whitfield-Gabrieli S
    Mol Psychiatry; 2020 Oct; 25(10):2431-2440. PubMed ID: 30410064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
    Kikinis Z; Cho KIK; Coman IL; Radoeva PD; Bouix S; Tang Y; Eckbo R; Makris N; Kwon JS; Kubicki M; Antshel KM; Fremont W; Shenton ME; Kates WR
    Brain Imaging Behav; 2017 Oct; 11(5):1353-1364. PubMed ID: 27730479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
    Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition.
    Borgwardt S; Koutsouleris N; Aston J; Studerus E; Smieskova R; Riecher-Rössler A; Meisenzahl EM
    Schizophr Bull; 2013 Sep; 39(5):1105-14. PubMed ID: 22969150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.
    Koutsouleris N; Riecher-Rössler A; Meisenzahl EM; Smieskova R; Studerus E; Kambeitz-Ilankovic L; von Saldern S; Cabral C; Reiser M; Falkai P; Borgwardt S
    Schizophr Bull; 2015 Mar; 41(2):471-82. PubMed ID: 24914177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.